Dr. Lal Pathlabs Share Price
Small Cap | Pharmaceuticals and health care | NSE: LALPATHLAB | BSE: 539524
₹2,515.70 
0.85 (0.03 %)
Last Updated: 04 Apr 2025 03:58 PM
BEARISH
Overview
Open (₹) 2,510.00
High (₹) 2,541.00
Low (₹) 2,465.00
Prev. Close (₹) 2,514.85
Volume 1,01,673
VWAP (₹) 2,323.49
ROCE (%) 26.86
Industry P/E 96.77
TTM P/E 50.46
P/B Ratio 11.14
Market Cap (₹) Cr.21,029.17
Dividend Yield (%)0.95
EPS (₹) 42.98
ROE19.03%
Sales Growth (%) 10.40
Profit Growth (%)50.28
Day Range
2,541.002,541.00
52 Week Range
2,168.803,645.00
Historical Returns
Returns (6M)
-27.29 %
Returns (1Y)
10.13 %
Returns (3Y)
-6.83 %
Returns (5Y)
81.01 %
Returns (6M)
-27.29 %
Returns (1Y)
10.13 %
Returns (3Y)
-6.83 %
Returns (5Y)
81.01 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (49.55%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 49.55% positive TTM EPS growth
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 20.00
MFI 12.09
ATR 82.95
Commodity Channel Index -191.69
ROC125 -31.29
ROC21 -19.72
Williams %R -98.04
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 2,345.86 | 2,381.28 | 2,404.21 | 2,322.93 | 2,287.51 | 2,264.58 | 2,229.16 |
| Week Ago | 2,637.64 | 2,675.77 | 2,721.59 | 2,591.82 | 2,553.69 | 2,507.87 | 2,469.74 |
| Month Ago | 2,740.29 | 2,798.62 | 2,835.29 | 2,703.62 | 2,645.29 | 2,608.62 | 2,550.29 |
EMA & SMA
2515.70
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
18
5 Day 2502.28
9 Day 2549.31
10 Day 2553.26
12 Day 2590.03
14 Day 2608.77
20 Day 2674.15
26 Day 2696.58
50 Day 2813.26
100 Day 2987.92
200 Day 2991.31
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| MULTI-MANAGER ICVC | bulk | Sell | 06 Jan, 2025 | ₹2,997.11 | 4,34,943 | NSE |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 03 Oct, 2022 | ₹2,518.75 | 8,417 | NSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Oct, 2022 | ₹2,518.75 | 45,068 | NSE |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 03 Oct, 2022 | ₹2,518.75 | 8,417 | NSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Oct, 2022 | ₹2,518.75 | 45,068 | NSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 27 Mar, 2025 | Dr. Lal PathLabs Employee Welfare Trust | Disposal | ₹160.84 | 1,263 | NSE |
| 27 Mar, 2025 | Punit Sharma | Disposal | ₹2,499.57 | 500 | NSE |
| 19 Mar, 2025 | Om Prakash Manchanda | Disposal | ₹2,558.52 | 20,000 | NSE |
| 12 Mar, 2025 | Dr. Lal PathLabs Employee Welfare Trust | Disposal | ₹10.00 | 538 | NSE |
| 07 Mar, 2025 | Prashant Kishore | Acquisition | ₹10.00 | 1,124 | NSE |
| 07 Mar, 2025 | Punit Sharma | Acquisition | ₹2,052.50 | 500 | NSE |
| 07 Mar, 2025 | Shankha Banerjee | Acquisition | ₹10.00 | 1,000 | NSE |
| 07 Mar, 2025 | Dr. Lal PathLabs Employee Welfare Trust | Disposal | ₹415.95 | 3,849 | NSE |
| 07 Mar, 2025 | Rahul Sharma | Disposal | ₹2,504.88 | 1,250 | NSE |
| 07 Mar, 2025 | Om Prakash Manchanda | Disposal | ₹2,504.23 | 11,653 | NSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 30 Jan, 2025 | Rs.6.0000 per share(60%)Third Interim Dividend | 05 Feb, 2025 | 05 Feb, 2025 |
| 23 Oct, 2024 | Rs.6.0000 per share(60%)Second Interim Dividend | 05 Nov, 2024 | 05 Nov, 2024 |
| 07 Aug, 2024 | Rs.6.0000 per share(60%)Interim Dividend | 20 Aug, 2024 | 20 Aug, 2024 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 31 Mar, 2025 | NSE India | Dr. Lal Path Labs Ltd. has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 31 Mar, 2025 | BSE India | Disclosure attached |
| 31 Mar, 2025 | NSE India | Dr. Lal Path Labs Ltd. has informed the Exchange that Dr. Om Prakash Manchanda (DIN: 02099404), stepped down as Managing Director (KMP) and ceased as a Director of the Company with effect from March 31, 2025 (closing of business hours). |
| 25 Mar, 2025 | NSE India | DR. LAL PATH LABS LTD. has informed the Exchange about Closure of Trading Window |
| 25 Mar, 2025 | NSE India | Dr. Lal Path Labs Ltd. has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 20 Mar, 2025 | BSE India | Intimation of Schedule of Analyst/ Institutional Investor Meeting(s) |
| 20 Mar, 2025 | NSE India | Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet |
| 19 Mar, 2025 | NSE India | Dr. Lal Path Labs Ltd. has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL |
| 18 Mar, 2025 | BSE India | Attached |
| 18 Mar, 2025 | NSE India | Dr. Lal Path Labs Ltd. has informed the Exchange about Update on Voluntary Liquidation of Suburban Diagnostics (India) Private Limited, Wholly Owned Subsidiary |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results, Dividend & Others | To consider other business matters. | 24 Jan, 2025 | 30 Jan, 2025 |
| Quarterly Results & Interim Dividend | -- | 17 Oct, 2024 | 23 Oct, 2024 |
| Quarterly Results & Interim Dividend | -- | 01 Aug, 2024 | 07 Aug, 2024 |
| Audited Results & Final Dividend | -- | 07 May, 2024 | 10 May, 2024 |
| Quarterly Results & Interim Dividend | -- | 30 Jan, 2024 | 01 Feb, 2024 |
| Quarterly Results | -- | 26 Oct, 2023 | 02 Nov, 2023 |
| Quarterly Results & Interim Dividend | -- | 21 Jul, 2023 | 27 Jul, 2023 |
| Audited Results & Final Dividend | -- | 04 May, 2023 | 11 May, 2023 |
| Quarterly Results | -- | 25 Jan, 2023 | 02 Feb, 2023 |
| Quarterly Results | -- | 02 Nov, 2022 | 08 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
|---|---|---|---|---|---|
| Promoter Group | 53.91% | 54.6% | 55.05% | 55.23% | 55.23% |
| Foreign Institutions + | 26.82% | 25.36% | 25.8% | 25.45% | 24.37% |
| Domestic Institutions + | 13.17% | 9.56% | 6.2% | 6.58% | 8.84% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 5.82% | 10.11% | 12.39% | 12% | 10.65% |
| Others | 0.28% | 0.37% | 0.56% | 0.74% | 0.91% |
About Dr. Lal Pathlabs
Dr. Lal Pathlabs is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388. Currently Company is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 1966.76 Cr. and Equity Capital is Rs. 83.48 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1995
Managing Director
Dr. Om Prakash Manchanda
NSE Symbol
LALPATHLAB
Dr. Lal Pathlabs Management
| Name | Designation |
|---|---|
| Brig.(Hony) Dr. Arvind Lal | Executive Chairman |
| Dr. Om Prakash Manchanda | Managing Director |
| Dr. Vandana Lal | Whole Time Director |
| Mr. Rahul Sharma | Non Executive Director |
| Dr. Archana Lal Erdmann | Non Executive Director |
| Mr. Gurinder Singh Kalra | Independent Director |
| Mr. Rajit Mehta | Independent Director |
| Mrs. Somya Satsangi | Independent Director |
| Mr. Rohit Bhasin | Independent Director |
| Mr. Arun Duggal | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Max Healthcare Institute | ₹1,10,595.74 | ₹1,137.65  ₹1,121.30(1.46%) | ₹743.000 - ₹1,227.500 |
| Apollo Hospitals Enterprise | ₹96,544.93 | ₹6,714.55 ₹6,671.35(0.65%) | ₹5,690.800 - ₹7,545.100 |
| Fortis Healthcare | ₹49,030.76 | ₹649.45  ₹659.70(-1.55%) | ₹406.350 - ₹744.000 |
| Narayana Hrudayalaya | ₹34,280.50 | ₹1,677.45 ₹1,663.45(0.84%) | ₹1,087.800 - ₹1,725.000 |
| Global Health | ₹33,149.05 | ₹1,234.20 ₹1,239.55(-0.43%) | ₹936.050 - ₹1,510.100 |
FAQs on Dr. Lal Pathlabs
What is the share price of Dr. Lal Pathlabs?
The share price of Dr. Lal Pathlabs on 04 Apr, 2025 is ₹ 2,515.70.
What is 52W high and 52W low share price of Dr. Lal Pathlabs?
The highest and lowest 52W share prices of Dr. Lal Pathlabs are ₹ 3645.000 and ₹ 2168.800
What is the market cap of Dr. Lal Pathlabs?
The market capitalization of Dr. Lal Pathlabs as of 04 Apr, 2025 is ₹ 21,029.17 Crores
What is the P/E ratio of Dr. Lal Pathlabs?
The current P/E ratio of Dr. Lal Pathlabs as of 04 Apr, 2025 is 96.77
What is the PB ratio of Dr. Lal Pathlabs?
The PB ratio of Dr. Lal Pathlabs as of 04 Apr, 2025 is 11.14
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)